Scancell Holdings Plc Ord


By |


Scancell Holdings PLC is engaged in the discovery and development of novel vaccines for the treatment of cancer. Scancell is exploiting the unrivaled potential of the immune system to seek out and destroy cancer using two proprietary immuno-oncology platforms: ImmunoBody and Moditope. Scancell's potent innovative DNA-based ImmunoBody therapies generate ultra-high avidity T cell responses that target and eliminate cancerous tumors. Scancell's Moditope platform technology overcomes the immune suppression induced by tumors themselves, allowing activated T cells to seek out and kill tumor cells that would otherwise be hidden from the immune system.

Contact Information

Main Phone: +44 1865338069
Address: Robert Robinson Avenue
Address 2: John Eccles House, Oxford Science Park
City / Town: Oxford
Country: GBR
Postal Code: OX4 4GP

Issuer Information

Exchange: GREY
CEO: Clifford Michael Holloway
Employees: 19
NAICS: 541711
$ 0.13 $ 0. (0.00%)
Last Price 0.13 Change $ 0. Change % 0.00 Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open N/A High N/A Low N/A Prev Close 0.13
Last Trade Volume 0 52 Wk Hi 0.25 52 Wk Low 0.13
Market Cap 48.5 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 387,796,556.00 EPS (TTM) N/A PE Ratio N/A Exchange Greys